Head of Global Medical & Scientific Affairs
Glucose Monitoring and Science
Roche Diabetes Care GmbH
Tel: +49 621 759 2254
Fax: +49 621 759 78 2254
Rolf Hinzmann, (MD, PhD) , is Head of Global Medical Affairs, Glucose Monitoring and Sciencefor Roche Diabetes Care based in Mannheim, Germany. In his current role he provides medical support for Roche Diabetes Care in the field of self-monitoring of blood glucose and continuous glucose monitoring.
Dr. Hinzmann studied Medicine and Biochemistry at Hannover Medical School and Hannover University, Germany. He completed his PhD in Biochemistry at the Max Planck Institute for Experimental Endocrinology in Hannover on the fluctuation of the estradiol receptor expression in the porcine ovary during the menstrual cycle. Thereafter, he worked in the field of laboratory diagnostics (clinical chemistry, immunology, haematology, immunohaematology, blood banking, microbiology, serology, molecular biology) and internal medicine at Hannover Medical School and qualified as Clinical Pathologist(in German: Arzt für Laboratoriumsmedizin).
In 1996 Dr. Hinzmann continued his medical career in the in-vitro diagnostic industry where he spent the past 18 years in various management positions: at Beckman Coulter in Munich, Germany, as a European Scientific Marketing Manager, at Sysmex Europe as Medical Director Europe, and since 2010 in the above-mentioned position at Roche. For several years Dr. Hinzmann represented Beckman Coulter and Sysmex Europe, respectively, in the Working Group Science & Technology in the Association of German Diagnostic Manufacturers (VDGH). He also served as a Member of the Area Committee Haematology in the Clinical and Laboratory Standards Institute (CLSI).
Dr. Hinzmann has many publications in the field of clinical chemistry, haematology and diabetes and is a requested lecturer at scientific conferences. Several times he was rated distinguished speaker by the American Association of Clinical Chemistry AACC.
His special interests are evidence-based medicine, cardiovascular disease, diabetes and metabolism, standardization of laboratory tests, point-of-care testing, self-empowerment of patients and behavioural change, screening and risk assessment in medicine, didactics and philosophy of science.
Since 2001 Dr. Hinzmann held various positions in the IFCC: as Corporate Representative of the Executive Committee of the Scientific Division (2001-2006), as Corporate Representative of the Executive Committee of the Education & Management Division (2007-2012) and as Member of the Task Force POCT (2013-2014).
In his role as Executive Board Corporate Representative he acts as the interface between IFCC and the in-vitro diagnostic industry.